Effects of estrogen on the vascular wall: vasomotor function and inflammation
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Time for primary review 33 days. Far from being only an anatomic barrier to prevent the influx of circulating blood into the vessel wall, the endothelium is a metabolically active organ system that maintains vascular homeostasis. The endothelium modulates vascular tone, regulates local cellular growth and the deposition of the extracellular matrix, protects the vessel from the potentially harmful consequences of substances and cells circulating in the blood, and mediates the hemostatic, inflammatory, and reparative responses to local injury. Nitric oxide (NO) produced by the endothelium plays a pivotal role in maintaining vascular health and protecting against vascular injury. Conditions such as hypercholesterolemia [1], systemic hypertension [1], and estrogen deficiency [2] have been associated with impaired functions of the endothelium. As a result of impairment, the vessel wall may promote inflammation, oxidation of lipoproteins, smooth muscle cell proliferation, extracellular matrix deposition or lysis, accumulation of lipid-rich material, the activation of platelets (which promote clotting), and thrombus formation. All of these consequences of endothelial dysfunction may contribute to the development and clinical expression of atherosclerosis and coronary heart disease [3,4]. This hypothesis is supported by serial angiographic studies carried out before and after a myocardial infarction, which indicate that the underlying plaque responsible for unstable angina and myocardial infarction usually produces an arterial narrowing of less than 50% before the acute event [5,6]. Indeed, a recent angiographic study suggests that the positive correlation between the number of severely diseased arteries and coronary mortality may not just be related to the number of arteries with 70% or greater stenosis, but may also be tied to the amount of minor plaque disease in other vessels [7]. These observations have driven a search for other mechanisms, including the potential association of endothelial dysfunction and associated inflammation with plaque rupture, and the activation of platelets and coagulation with thrombus formation. Advances in research in this area are particularly relevant to the health of older women, since cardiovascular disease (CVD) results in more deaths in women in the United States than any other disease. Several prospective, observational studies have suggested that postmenopausal women who do not have documented cardiovascular disease and who take estrogen replacement therapy (ERT) or hormone replacement therapy (HRT—estrogen plus a progestin) have a reduced risk of major coronary events compared with untreated women [8–10]. In contrast, the Heart and Estrogen/progestin Replacement Study (HERS) [11], a randomized controlled trial among older women with established heart disease, found an increased risk of cardiovascular events in the first year of treatment in this at-risk cohort. This result, in part, has led the American Heart Association [12] to advise against the initiation of HRT for the secondary prevention of CVD, or for the sole purpose of the primary prevention of CVD until the results of ongoing randomized trials are reported and analyzed. The potential atheroprotective effects of estrogen have been attributed principally to the hormone's effects on serum lipid concentrations [13,14]. However, estrogen-induced alterations in serum lipids account for only approximately one-third of the observed reduction in risk of mortality from CVD among ERT or HRT users [15]. Based on the literature done by others and our group, this article reviews the influence of ERT or HRT on such aspects of endothelial function as vasomotor function and inflammation as plausible mechanisms in the prevention of atherosclerosis and coronary heart disease in postmenopausal women. We recently reviewed the effects of HRT on hemostasis and thus will not discuss this topic in this review [16]. Growing evidence over the past decade implicates chronic inflammation in the pathogenesis of atherosclerosis (Fig. 1) [3]. Human coronary, carotid, and aortic specimens at necropsy have shown infiltration of the intima and media by granulocytes, lymphocytes, monocytes, and macrophages [17–19]. The initiation of inflammation is probably multifactorial; more recently described risk factors include infectious pathogens [20], homocysteine [21], and lipoprotein(a) [Lp(a)] [22]. Injury to the arterial surface activates endothelial cells and initiates synthesis of protein mediators of inflammation. Monocytes attracted into the vessel wall are transformed into macrophages, which incorporate oxidized lipoproteins, becoming lipid-laden foam cells. Once activated by injury, endothelial and smooth muscle cells of large arteries become transcriptionally active and synthesize proinflammatory proteins, including: (1) chemokines and cell adhesion molecules (CAMs), which attract circulating inflammatory cells to the arterial surface and facilit
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229
Marui, N., Offermann, M. K., Swerlick, R., Kunsch, C., Rosen, C. A., Ahmad, M., Alexander, R. W., & Medford, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116778 · Cited by 1,072
Grodstein, F., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., & Stampfer, M. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00008 · Cited by 1,063
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Cited by
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,555
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318277d6a0 · Cited by 845
Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol
Vegeto, E., Belcredito, S., Etteri, S., Ghisletti, S., Brusadelli, A., Meda, C., Krust, A., Dupont, S., Ciana, P., Chambon, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531957100 · Cited by 382
Inflammatory Markers and the Metabolic Syndrome
Koh, K. K., Han, S. H., & Quon, M. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.082 · Cited by 368
Self-citation
Metadata
- Authors
- Koh, K.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-09
- Volume
- 55
- Issue
- 4
- Pages
- 714-726
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W1994050458
- Cited by
- 108
- References
- 9
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of estrogen on the vascular wall: vasomotor function and inflammation. https://app.cochat.ai/papers/10.1016/s0008-6363(02)00487-x
- The paper
- Koh, K. (2002). Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(02)00487-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.